Stent thrombosis after sirolimus- and paclitaxel-eluting stent implantation in daily clinical practice: Analysis of a single center registry

Catheterization and Cardiovascular Interventions

Volumn 70, Issue 3, 2007, Pages 415-421

  Trabattoni, Daniela ^a   Fabbiocchi, Franco ^a   Montorsi, Piero ^a   Ravagnani, Paolo ^a   Galli, Stefano ^a   Teruzzi, Giovanni ^a   Calligaris, Giuseppe ^a   De Martini, Stefano ^a   Bartorelli, Antonio L ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

Author keywords

Drug eluting stents; Percutaneous coronary intervention; Stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; PACLITAXEL; RAPAMYCIN; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; BIOMATERIAL;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; DOSE RESPONSE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; INTRAVASCULAR ULTRASOUND; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; RISK ASSESSMENT; ST SEGMENT ELEVATION; THROMBOSIS; VASCULAR DISEASE; VASCULAR LESION; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; BLOOD VESSEL TRANSPLANTATION; CORONARY ARTERY THROMBOSIS; GRAFT OCCLUSION; INCIDENCE; INSTRUMENTATION; ITALY; PROSPECTIVE STUDY; RADIOGRAPHY; STENT;

ANGINA PECTORIS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; FEMALE; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HUMANS; INCIDENCE; ITALY; MALE; PACLITAXEL; PROSPECTIVE STUDIES; SIROLIMUS; STENTS;

EID: 35848960799     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21149     Document Type: Article

References (23)

1. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
2. Stone GW, Ellis GC, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231.
3. Farb A, Heller FH, Shroff S, et al. Pathologic analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 2001;104:473-479.
4. Aloke VF, Kolodgie FD, Harnek J, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- and paclitaxel-eluting stents. Circulation 2005; 112:270-278.
5. Moreno R, Fernández C, Hernández R, et al. Drug-eluting stent thrombosis: Results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005;45:954-959.
6. Bavry AA, Kumbhani DJ, Helton TJ, et al. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary interventions. J Am Coll Cardiol 2005;45:941-946.
7. Cutlip DE, Bairn DS, Ho KK, et al. Stent thrombosis in the modern era: A pooled analysis of multicenter coronary stent clinical trials. Circulation 2001;1003:1967-1971.
8. Ong ATL, Hoye A, Aoki J, et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005;45:947-953.
9. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-2130.
10. Andrew TL, Ong MBBS, McFadden E, et al. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005;45:2088-2092.
11. Urban P, Gershlick G, Guagliumi G, et al. Safety of coronary sirolimus-eluting stents in daily clinical practice: One-year follow-up of the e-CYPHER registry. Circulation 2006;113:1434-1441.
12. Fujii K, Carlier SC, Mintz GS, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation. J Am Coll Cardiol 2005;45:995-998.
13. Cheneau E, Leborgne L, Mintz GS, et al. Predictors of subacute stent thrombosis. Results of a systematic intravascular ultrasound study. Circulation 2003;108:43-47.
14. Alfonso F, Suarez A, Angiolillo DL, et al. Findings of intravascular ultrasound during acute stent thrombosis. Heart 2004;90: 1455-1459.
15. Chieffo A, Bonizzoni E, Orlic D, et al. Intraprocedural stent thrombosis during implantation of sirolimus-eluting stents. Circulation 2004;109:2732-2736.
16. Oemrawsingh PV, Mintz GS, Schalij MJ, et al. Intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenosis: Final results of a randomised comparison with angiographic guidance (TULIP study). Circulation 2003;107:62-67.
17. Jeremias A, Sylvia B, Bridges J, et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 2004; 109:1930-1932.
18. Morice MC, Colombo A, Meier B, et al. Sirolimus- versus Paclitaxel-eluting stents in de novo coronary artery lesions. The REALITY trial: A randomized controlled trial. JAMA 2006; 295:895-904.
19. Kastrati A, Mehilli J, von Beckerath N, et al. Sirolimus-eluting stent or paclitaxel-eluting stent versus balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: A randomized controlled trial. JAMA 2005;293:165-171.
20. Liistro F, Colombo A. Late acute thrombosis after paclitaxel eluting stent implantation. Heart 2001;86:262-264.
21. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-1521.
22. Kaluza GL, Joseph J, Lee JR, et al. Catastrophic outcome of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000;35:1288-1294.
23. Wilson SH, Fasseas P, Oxford JL, et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003;42:234-240.